OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells presents a paramount challenge for the biopharmaceutical industry. Multiple strategies have been employed maximize antibody titer, including process parameter optimization, genetic engineering, and implementation of perfusion systems. Fine-tuning media co